OptraSCAN's Partnership with Page To Streamline Digital Pathology Adoption

1
Paige and OptraSCAN Partner to Streamline Digital
Pathology Adoption
September 22, 2022 1000 AM Eastern Daylight Time
Paige, a global leader in end-to-end digital pathology solutions Paige, a global leader in end-to-end digital pathology solutions Paige, a global leader in end-to-end digital pathology solutions
and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today and clinical AI applications, and OptraSCAN, a leading producer of whole slide scanners, today
announced a partnership to streamline the adoption of digital pathology technology in the announced a partnership to streamline the adoption of digital pathology technology in the announced a partnership to streamline the adoption of digital pathology technology in the
United States, European Union countries and United Kingdom. The companies aim to reduce United States, European Union countries and United Kingdom. The companies aim to reduce United States, European Union countries and United Kingdom. The companies aim to reduce United States, European Union countries and United Kingdom. The companies aim to reduce
barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology
and oncology.
NEW YORK--(BUSINESS WIRE)--
This collaboration is an important step in our
mission to unlock the full potential of AI in
routine clinical use and provide healthcare
professionals with precise insights to help
patients get the most effective care.
2
Together, the companies will integrate Paiges
clinical AI applications and interoperable
enterprise imaging platform with OptraSCANs
digital pathology scanner to offer advanced end-
to-end digital pathology workflow solutions. This
provides a streamlined path for pathologists to
adopt Paiges leading suite of digital pathology
applications, including the FDA-cleared
FullFocus whole-slide image viewer and AI
applications including Paige Prostate Suite and
Paige Breast Suite alongside OptraSCANs
affordable digital pathology scanners. OptraSCAN
devices have 15 to 480 slide loading capabilities
that digitize the glass slides at 40x in less
than one minute per slide with patented composite
imaging offering.
We are excited to work with OptraSCAN to make it
easier for labs and healthcare networks around
the world to adopt digital pathology workflows,
said Andy Moye, Ph.D., Chief Executive Officer at
Paige. This collaboration is an important step
in our mission to unlock the full potential of AI
in routine clinical use and provide healthcare
professionals with precise insights to help
patients get the most effective care. Abhi
Gholap, Founder and CEO of OptraSCAN said,
OptraSCANs mission to enable pathology slide
digitization at fractional costs is eventually
resulting into higher market demand for digital
pathology applications. This partnership with
Paige will facilitate adoption of digital
Explore how our solutions can specifically help
you
Schedule a Demo
Download Brochure
OptraSCAN is an ISO13485 certified
company. OptraSCAN whole slide scanners are CE
marked for IVDR use. OptraSCAN Systems are for
research use only in North America. infrastructure
for global clinical and molecular pathology
community in an efficient way.
3
(No Transcript)